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ABSTRACT    
Aim: This paper is a report of a study to describe nurses’ perceptions of decision-
making and the evidence-base for the initiation of insulin therapy.  
 
Background: Several theoretical perspectives and professional’s attributes underpin 
decision-making to commence insulin therapy.  The management of type 2 diabetes is 
moving from secondary to primary care and this affects how clinical decisions are 
made, by whom and the evidence-base for these decisions.   
 
Method: A postal survey was conducted with a stratified sample of 3478 Diabetes 
Specialist Nurses and Practice Nurses across the four countries of the United 
Kingdom with a special interest in diabetes. A total of 1310 valid responses were 
returned, giving a response rate of 37.7%.  A questionnaire was designed for the study 
and pilot-tested before use. Responses were given using Likert-type scales. Data were 
collected during 2005 and 2006, and one reminder was sent. 
 
Results: People with diabetes are seen as having little influence in decision-making. 
Consultant physicians appear to be influential in most decisions, and the nursing 
groups held varying perceptions of who made clinical decisions. Nurses’ identified 
different responsibilities for those working solely in secondary care from those 
working in both community and secondary care. Practice nurses were not as 
involved as anticipated. 
 
Conclusion: Nurses working with people with diabetes need to encourage them to 
become more active partners in care. Clinical guidelines can assist in decisionmaking 
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where nurses are least experienced in initiating insulin therapy. 
 
Keywords: adults, decision-making, diabetes, insulin initiation, nurses, questionnaire, 
survey 
 
SUMMARY 
What is already known about this topic 
• Complex healthcare interventions, multiprofessional team-working and 
empowering patients all contribute to creating a challenging environment in 
which decisions about patient care are made.  
• There is relatively little decision-making in the management of people with 
type 1 diabetes, but in type 2 diabetes there are many clinical options available 
of which insulin is one. 
• There are wide variations of practice with regard to insulin initiation, 
especially in relation to people with type 2 diabetes 
 
What this paper adds 
• People with diabetes and their carers were not seen as active partners in the 
decisions about initiation of insulin treatment. 
• Consultant physicians held key roles in decision-making, regardless of type of 
diabetes.  
• Diabetes Specialist Nurses appeared to have different influences on insulin 
initiation depending on the type of diabetes and care setting, while Practice 
Nurses did not seem to be key professionals in insulin initiation. 
INTRODUCTION 
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It is estimated that diabetes is the fifth leading cause of death globally (Roglic et al 
2005). This constitutes a pandemic, with 80% of these people having type 2 diabetes 
(Amos et al 1997). The definitive United Kingdom Prospective Diabetes Study 
(UKPDS) demonstrated the need for people with type 2 diabetes to commence insulin 
therapy sooner than previously thought (UKPDS 1998a, 1998b), although the 
evidence-base does not suggest insulin regimes, types or doses. 
 
To address these projected healthcare needs, the United Kingdom (UK) has moved 
from a specialist model of care to one in which diabetes management is effectively 
conducted in primary care, with referral to specialist services as needed. In the UK 
there is a National Health Service in which care is provided free at the point of 
delivery and targets for clinical management are set at a national level. Chronic 
disease management here is multiprofessional, and nurses have a leading role in the 
care of people with diabetes. The initiation of insulin therapy has traditionally been 
the role of Diabetes Specialist Nurses (DSNs).  However, with developments in care, 
Practice Nurses (PNs) are being further educated in diabetes and commencing insulin 
therapy for people with type 2 diabetes in the community.   
 
BACKGROUND 
A literature review was undertaken on decision-making in diabetes. Databases Current 
Index to Nursing and Allied Health Literature, OVID, Cochrane Database of 
Systematic Reviews, American College of Physicians Journal Club, Database of 
Abstracts of Reviews of Effects, Cochrane Control Trials Register, British Nursing 
Index and Medical Literature Analysis and Retrieval System were searched from 1982 
– 2006 using the keywords decision-making; diabetes mellitus; insulin; child; diabetes 
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specialist nurse; clinical nurse specialists; community health nursing; physicians; 
families; consultant physicians; blood glucose; haemoglobin A; glycosylated 
haemoglobin; insulin start dose; insulin dosage calculation; practice nursing; clinical 
parameters.  Results were refined and honed until literature relevant to this study was 
identified.  
 
Language and theories 
Complex healthcare interventions, multiprofessional team working and empowered 
patients all contribute to creating a challenging environment in which decisions about 
patient care are made. However, decision-making itself has no clear definition and 
many terms are used to describe it: clinical decision-making, clinical judgement, 
clinical inference, clinical reasoning, diagnostic reasoning, decision analysis, intuitive 
reasoning, evidence-based care, critical thinking, discriminative thinking, pattern 
matching (Thompson 1999, Hallett et al 2000, Buckingham & Adams 2000a, 
Buckingham & Adams 2000b, Harbison 2001, Bliss & While 2003, Rashotte & 
Carnevale 2004, Bakalis & Watson 2005, Dowding & Thompson 2004).  The 
variability of language results in different understandings that are much debated and 
researched.  A few theories of decision-making provide a framework in which to 
understand this concept. 
 
Thompson (1999) has proposed three theoretical stances. First, he discusses the 
systematic-positivist stance that considers decision-making as a hypothetico-deductive 
rational process.  Here, decision-making is a linear process and a pragmatic approach 
is adopted (Hallett et al 2000). The process requires both induction and deduction 
(Buckingham & Adams 2000a). The field of cognitive psychology provides the 
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theoretical underpinning, and an information processing model provides the 
framework.  A sound knowledge-base is required (Arries & Nel 2004), although 
Thompson et al (2004) found that nurses relied on experienced human sources for 
evidence as opposed to research itself.  This confirms earlier findings that the largest 
source for influencing practice was practice-based knowledge (Luker & Kendrick 
1992).  The second theoretical stance proposed by Thompson (1999) is the intuitive-
humanistic theory that uses intuitive judgment and separates the novice from the 
expert, thus building on the work of Benner (1984), and expertise is thought to be 
acquired through experience (Rashotte & Carnevale 2004).  Both the systematic-
positivist stance and intuitive-humanistic theories have strengths and limitations. 
Common themes identified in both theories are communicability, simplification, 
context specificity and applicability. Thompson (1999) considers that while each have 
something to offer, it may be more appropriate to consider a third theory - the 
cognitive continuum.  The cognitive continuum, as a framework for research is 
appropriate for multidisciplinary team-working where others may be perceived as 
‘experts’ in clinical positions.  
 
Theories of decision-making, therefore, draw on differing philosophical concepts and 
disciplines such as cognitive and social psychology, philosophy, artificial intelligence 
and statistical theories.  Other theories that explain decision-making use a utility 
approach, prospect theory or social cognition model (Bekker et al 1999).   
 
Smith Higuchi et al (2002) defined six major thinking processes of description, 
selection, representation, inference, synthesis and verification. They demonstrated that 
clinical decision-making is a complex cognitive process and that different thinking 
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skills were used in medical and surgical care settings. Rashotte & Carnevale (2004) 
further state that clinical decision-making appears to be a continuous, sequential 
learning process that requires three critical elements.  These elements are experiential 
learning, reflective practice and transformative learning.  They state that clinical 
decision-making is context-specific and is an ongoing process of sense-making.  
Hoffman et al (2004) identify several contextual factors of decision-making that 
include experience, education, level of appointment, area of practice, beliefs and 
values. 
 
Thompson et al (2004) stated that evidence-based decision-making is an active 
process, and that there needs to be a degree of fit between the information provided 
and the decision task. Rashotte & Carnevale (2004) state that decision-making is an 
exclusively cognitive function, thereby disregarding social phenomena that also have 
a bearing on this form of knowing.   
 
The nursing profession does not appear to agree on any one model or theory of 
decision-making; rather, this is seen as eclectic, dynamic and fluid (Rashotte & 
Carnevale 2004) rather than as a linear process (Bliss & While 2003) and may in fact 
embody both intuitive and diagnostic reasoning compatibility (Hallet et al 2000). 
Professionals’ own attributes may also affect decision- making. 
 
Professionals’ attributes 
 
Hoffman et al (2004) identified factors that accounted for the greatest variability in 
clinical decision-making: holding a professional occupational orientation; level of 
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appointment; area of clinical speciality and age. They found that neither education nor 
experience was statistically significantly related to decision-making. The value of the 
professionals’ role, as defined by a valid and reliable questionnaire, was the most 
statistically significant predictor over experience and educational level to strongly 
influence decision-making. However, the model they developed only accounted for a 
low amount of variability in decision-making.  
 
Bakalis & Watson (2005) found that length of clinical experience was statistically  
correlated to the frequency of decision-making, although there was no difference 
based on educational level of nurses.  Several authors suggest that less experienced 
nurses will use rules for decision-making, although this suggestion is not evidence-
based (Benner 1984, Rashotte & Carnevale 2004, Dowding & Thompson 2004). 
Thompson et al (2004) found that education and clinical experience were poor 
predictors of how useful nurses found protocols and guidelines for decision-making in 
clinical practice.   
 
Patient involvement 
If decision-making involves theoretical knowledge and experience being applied to a 
clinical situation, it could be argued that patients are the passive recipients of 
professional care.  However, in chronic disease management, patients become experts 
in their own conditions and hence demonstrate theoretical knowledge and experience.  
 
 
A Health Technology Assessment team reviewed 825 papers on decision-making, of 
which 547 were included in the report (Bekker et al 1999). Of these studies, only 26 
 8
explicitly involved patients in the decision-making process (Bekker et al 1999).  In an 
observation study, Millard et al (2006) looked at community nurses’ involvement of 
patients in the decision-making process. They identified five types of patient 
behaviour in decision-making on an ‘involving-non-involving’ continuum and found 
that nurses could promote or deter involvement in decision-making through their 
communication skills. While healthcare philosophy promotes patient empowerment 
and participation, the reality is that participation in clinical decision-making from a 
patient and carer perspective is a complex concept (Thynne et al 2003, Claassen 2000) 
and may be facilitated, or not, by healthcare professionals (Millard et al 2006, Gravel 
et al 2006).  However, Florin et al (2006) found that nurses thought that patients 
wanted greater involvement in decision-making than the patients actually said they 
wanted.  
  
Shared decision-making 
A systematic review of shared decision-making in clinical practice as perceived by 
healthcare professionals has recently been published (Gravel et al 2006).  Of almost 
1000 references reviewed, only 31 met the inclusion criteria.  The most-cited barriers 
to involving patients in decision-making were time constraints, lack of applicability 
due to patient characteristics and the clinical situation.  Other factors cited were 
perceived patient preferences for a model of decision-making that did not fit with a 
shared decision-making model and not agreeing with asking patients about their 
preferred role in decision-making (Gravel et al 2006).   
 
Gravel et al (2006) reported the facilitating factors for shared decision-making as 
motivation from healthcare professionals, positive impact on the clinical process, 
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positive impact on patient outcomes.  This suggests that healthcare professionals 
anticipate a positive outcome before trying to involve patients in decision-making, 
demonstrating a paternalistic approach to care and not fully engaging with a shared 
care philosophy.  Other factors facilitating shared decision-making were perceptions 
that shared decision-making is useful and or practical, patient preference for a shared 
decision-making model, and patient characteristics. However, the systematic review 
included mostly work conducted with physicians, and very little is known about other 
healthcare professionals (Gravel et al 2006).   
 
Patient involvement is increasingly emphasised in all aspects of care through the UK 
National Service Framework for Diabetes. In a study to develop a diabetes-specific 
scale to measure patient’s desire to participate in medical decision-making, it was 
found that there was a desire by patients for discussion and information but this might 
stop short of actual decision-making (Golin et al 2001).  In another study it was found 
that DSNs were most likely to choose the type of insulin, whereas patients were more 
likely to choose the injection device (Thynne et al 2003).   
 
Clinical decision-making is hard to define. It is influenced by the attributes of 
professionals themselves. While the philosophy of involving patients in decision-
making is being promoted, this is limited in practice partly by professionals. Shared 
clinical decision-making therefore between professionals and patients is still evolving. 
 
Insulin initiation 
There is relatively little decision-making in the management of people with type 1 
diabetes. Due to the autoimmune processes, people are dependent on exogenous 
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insulin for their survival (Matthews 2007). In type 1 diabetes, decisions relate more to 
the insulin regimen and the injection device rather than the need for insulin.  In type 2 
diabetes the decision about insulin therapy is less clear cut. There are many clinical 
options available to people with type 2 diabetes, of which commencing insulin is one. 
The UKPDS (1998a, 1998b) demonstrated the benefits of insulin therapy in 
preventing long-term complications of diabetes. Protocols represent an attempt to 
derive logarithms for care to ensure that people with type 2 diabetes start insulin 
relatively quickly after diagnosis (Nathan et al 2006).  In a literature review, Davis et 
al (2006) concluded that there were wide variations of practice with regard to insulin 
initiation, especially for people with type 2 diabetes in the UK. 
 
THE STUDY 
Aim  
The aim of the study was to describe nurses’ perceptions of decision-making and the 
evidence base for the initiation of insulin in the United Kingdom 
 
The study objectives were:  
To identify the range of healthcare professionals who influence the decision 
that a person needs to commence insulin and nurses’ perceptions of their 
influence.   
 
To identify the criteria used to determine when insulin treatment should be 
started. 
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To determine to what extent clinical decision-making is based on 
individualised assessment, protocols or other approaches. 
 
Design 
A survey approach was adopted using a pre-tested questionnaire.   
 
Participants 
All DSNs listed in a commercially-available database and an equivalent sample size 
of Practice Nurses (PNs) were the population for the study. Primary care practices 
with four or more GPs were chosen as they were considered more likely to offer a 
structured diabetes service including insulin initiation.  Questionnaires were sent to 
practices and addressed to PNs with a special interest in diabetes (PND) but, if none 
were employed, then the questionnaire could be completed by a generic PN. A sample 
of 3478 practitioners was identified by accessing all DSNs on the database (n=1739) 
and matching this number with the equivalent number of PNs working in primary care 
with 4 or more GPs (n=1739).  Stratified sampling methods were used to ensure that 
there were matched numbers of DSNs and PNs from the four countries of the UK, 
with the number of DSNs per country being the influencing number.  
 
The questionnaire 
The questionnaire had two sections.  In the first section respondents were asked about 
their perceptions of decisions related to initiating insulin at their place of work, while 
acknowledging that they personally might not be responsible for all aspects of this.  In 
the second section people were asked to respond in relation to their own personal 
practice. The same questions were asked in relation to people with type 1 or type 2 
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diabetes. Nurses were asked to score their own perceptions of the roles of those in 
their own professional group as well as how they perceived other nursing groups; 
responses were given on a Likert-type scale. Demographic details were captured at the 
end of the questionnaire.   
 
Pilot study 
A panel of experts ensured the face validity of the questionnaire, and it was piloted in 
both the UK and Australia and test-re-tested (n=150) prior to use. Those involved in 
the pilot study were excluded from the main study. The questionnaire was amended in 
light of comments received to ensure clarity and reduce range of responses.  
 
Data collection 
The questionnaire was distributed by post in November 2005, and a reminder letter 
was sent in January 2006.   
 
Ethical considerations 
The study was approved by the Office of Research Ethics Committee in Northern 
Ireland.  The keepers of the databases distributed the questionnaires to the identified 
sample to ensure anonymity. 
 
Data analysis 
Results were analysed using the Statistical Package for the Social Sciences version 11.  
Descriptive statistics were used and the differences between DSNs in secondary care 
(DSNSC), DSNs in primary care (DSNPC), DSNs working in both primary and 
secondary care (both) and PNDs were tested for statistically significant differences. 
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The threshold for statistical significance used was P <0.05, although some results 
achieved greater levels of statistical significance (P < 0.001). 
 
RESULTS 
A total of 1310 questionnaires was returned, giving a response rate of 37.7%. Of the 
returned questionnaires, 65 were returned blank with a covering note explaining why 
they were not completed, and therefore 1245 were analysed. A similar response rate 
was acquired from all four countries. Results are presented as totals, these vary as not 
every person answered each question.  
 
The results are also presented according to whether the data relate to the overall 
aspects of insulin initiation in the respondents’ place of work (n = 1245) or the 
individual’s personal practice (n = 492 type 1 diabetes; n = 785 type 2 diabetes). 
Thus, the sample size was reduced when   considering respondents’ personal practice. 
 
Of the respondents, 38.2% (n=474) were PNDs; 19% (n=235) were DSNSCs; 16.5% 
(n=205) were DSNs (Both); 12.8% (n=159) were DSNPCs with the remainder 
comprising generic PNs, nurse consultants and others (13.4%, n=157). Years of 
experience in this work varied from more than 10 years (27.2%, n=208) to over half 
having less than six years’ experience (57.1% n= 436).  When analysed by 
professional group, it appeared that PNDs had only recently started initiating insulin 
as the majority of them (72.8%, n=145 PNDs) had less than 3 years’ experience of 
this.  This is compared to 15.6% (n=36) of DSNSCs; 16.3% (n=32) of DSN (Both); 
and 34.8% (n=48) of DSNPCs with less than 3 years’ experience. These results were 
statistically significant  (x2 = 249.1, df=12, p<0.001).   
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 Most nurses who answered the question (93.3%, n=791) had attended a diabetes study 
day, with 49.3% (n=418) acquiring diploma level study.  Only a small percentage 
(13.4%, n=114) had studied at Masters’ degree level, and these were predominantly 
DSNs, with only three being PNDs.  
 
The aim of the study was to determine who makes the decision to commence insulin 
therapy in people with diabetes and the evidence base for the process. There were 
differing perceptions of the influence of professional groups on who made this 
decision.  These are presented by diabetes classification as there were differences 
according to the two types.   
 
Decision-making in type 1 diabetes  
Professionals’ perspectives  
The majority of respondents (73.7%, n=612) perceived consultant physicians, 
followed by the DSNSCs (57.6%, n=478) as having the most influence over the 
decision to commence insulin.  Few respondents indicated that people with diabetes, 
GPs or other medical staff had ‘a lot’ of influence.  Even fewer respondents thought 
that PNDs, general PNs or carers had ‘a lot’ of influence over the decision.  
 
Nurses’ perceptions of influence by professional group are presented in Table 1.  
Most groups perceived consultants as having ‘a lot’ of influence, while GPs had the 
least influence in decision-making.  DSNSCs saw themselves as having most 
influence over insulin initiation (80.1%, n=185), and those working across both 
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primary and secondary care as having ‘a lot’ of influence.  The groups who perceived 
themselves as having the least influence were DSNPCs and PNs.   
 
Over half of those who responded to this question (53.3%, n=417) indicated that the 
final decision to commence insulin in adults with type 1 diabetes was made by the 
consultant physician.  However, 23.8% (n=186) thought that the decision was made 
jointly and that no one professional group was responsible for the final decision.   
 
At a later stage in the questionnaire, those who personally initiated insulin were asked 
about their practice.  They replied that either the consultant or DSNSC were 
responsible for the majority of decisions about the type of insulin to be used in type 1 
diabetes (70.3%, n=360).  These respondents considered this to be a joint decision in 
only 15.2% (n=78) of situations.  
 
The evidence-base in type 1 diabetes 
Clinical guidelines are used more often to inform the decision-making process in type 
1 diabetes than clinical protocols or care pathways (Table 2).  Over a quarter of the 
respondents who responded in relation to their individual practice (28.8%, n=239) 
claimed not to use any structured process. 
 
Approximately half of those who responded ranked their clinical experience as used 
most often in determining the starting dose for people with type 1 diabetes (49.6% 
n=245); these respondents were predominantly those with more than 10 years’ 
experience (58.9% n=113), compared with 42.9% (n=3) of those with less than one 
years’ experience. Team agreement was rarely ranked first (13.9%  n = 64, Table 3). 
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On further analysis, numbers per category in Table 3 varied considerably from over 
10 years experience (n = 192); 1–10 years (n=288); less than one year (n=7). 
 
Decision-making in type 2 diabetes 
 
Professionals’ perspectives in type 2 diabetes 
Professional influence in the decision-making process to commence insulin therapy 
for people with type 2 diabetes differed from that for those with type 1 diabetes 
(Figure 1).  It was thought that the consultant had ‘a lot’ of influence (45.9%, n=499), 
with the DSNSC following (42.3%, n=459).  DSNPCs were the third most influential 
group at 36.0% (n=391). GPs (30.3%, n=329), people with diabetes (29.4%, n=319), 
and PNDs (26.6%, n=289) were perceived as being more prominent in this decision 
with people with type 2 diabetes than those with type 1 diabetes.   
 
Approximately a third of respondents thought that the final decision to initiate insulin 
therapy in people with type 2 diabetes was made jointly, and that no single health 
professional was responsible (34.2%, n=343).  Whilst the consultant physician was 
reported to make the final decision by 22.5% (n=226) of respondents, only 14.8% 
(n=149) reported that this was the GP’s responsibility.     
 
All DSNs saw themselves as having the greatest influence on the decision to 
commence insulin (Table 4). Consultant physicians, while appearing to have some 
influence, were not as influential here as in type 1 diabetes.  GPs were not considered 
very influential by anyone except the PNDs, who perceived GPs as wielding more 
influence than DSNs. 
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 The evidence-base in type 2 diabetes  
 
It would appear that guidelines were used more often than clinical protocols or care 
pathways to inform the decision-making process in type 2 diabetes (Table 2). Only 
18.0% (n=195) claimed not to use any structured process.  
 
Among those who personally initiated insulin therapy, almost half ranked their 
clinical experience as the most frequently-used method of determining the starting 
dose (48.3%, n=378). Respondents with more than 10 years’ experience of initiating 
insulin were less likely to use protocols, guidelines or pathways (17.7%, n=41) than 
those with less than one year of experience (12.9%, n=12).     
 
In descending order of frequency the following criteria were identified as having ‘a 
lot’ of  influence over deciding to start insulin: symptoms of hyperglycaemia (83.8%, 
n=693); rising HbA1c (80.3%, n=673); complications of diabetes (76.7%, n=636); 
patient choice (63.5%, n=527); ability to self care (61.3%, n=509); weight loss 
(58.5%, n=483); difficulties with tablets (51.5%, n=424); social situation (46.1%, 
n=381) and body mass index (32.0%, n=263).   
 
Analyses of these items by profession indicated some differences.  DSNSCs were less 
likely to give ‘a lot’ of consideration to a patient’s choice (52.4%, n=122) than those 
in other respondent groups (DSNPC: 73.0%, n=103; DSN Both: 61.7%, n=121; 
PNDs: 72.3%, n=146).  Similarly, the social situation was not given ‘a lot’ of 
consideration by DSNSCs (38.8%, n=90) compared with DSNPCs (49.3%, n=69) or 
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PNDs (49.0%, n=100).  PNDs were more likely than DSNs to give ‘a lot’ of 
consideration to rising HbA1c (88.8%, n=182) and less to symptoms of 
hyperglycaemia (77.2%, n=156).   
 
Patient choice (75.1%, n=636), clinical expertise (65.2%, n=552), recent research 
(51.1%, n=433) and local guidelines/protocols (49.2%, n=417) were the four 
influences cited most often by respondents as guiding the decision to initiate insulin in 
people with type 2 diabetes. 
 
DISCUSSION 
A response rate of 37.7% was achieved, and this is fairly typical from a postal 
questionnaire (Burns and Grove 2005). Some researchers would consider this poor 
(Bryman 2001), while others acknowledge that response rates are variable (Parahoo 
1997, Bowling 1997). A sample size calculation estimator 
(http://www.surveysystem.com/sscalc.htm) indicates that a response rate of a third 
would be considered representative of the wider population, and this was achieved.  
There was evidence of proportional representation from respondents between the four 
countries of the UK between DSNs and PNs and this is a strength of the study. 
 
The literature demonstrates that less experienced nurses use rules for decision-making 
(Benner 1984, Rashotte & Carnevale 2004, Dowding & Thompson 2004) and our 
results support this as experienced nurses stated that they used their clinical 
experience as opposed to protocols to determine the starting dose of insulin. 
Experienced nurses could be perceived as taking an intuitive-humanist stance, 
according to Thompson (1999). No explanation can be suggested in relation to 
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educational experience because of the small numbers holding Master’s degrees. In the 
UK, Master’s degree-level thinking is construed as advanced nursing practice 
(Scottish Government 2008). Experience and educational attainment would be worthy 
of further study as more nurses acquire diabetes-specific education at an advanced 
level. 
 
Nurses working in different clinical settings reported their own influence in decision-
making in the initiation of insulin according to diabetes type.  Responses from the 
differing care settings demonstrated that clinical decision-making about initiation of 
insulin is complex.  This may reflect custom and practice, where previously all those 
requiring insulin were managed in secondary care settings; however, it does raise 
some issues in relation to the role of DSNPCs, as it gives the impression that they do 
not feel as influential in care direction as those in secondary care. The data also 
suggest that PNDs do not yet feel that they have ‘a lot’ of influence in this decision.  
 
Commencing insulin in people with type 2 diabetes may be a complex decision, as 
described by Harbison (2001), and this may account for the differing picture evident 
in primary care.  However, it may be that as DSNPCs and PNs expand their roles 
there needs to be more transparency in decision-making between all members of the 
healthcare team to promote multiprofessional working, as proposed by Buckingham & 
Adams (2000a). 
 
There is no patient choice issue in whether to start insulin in people with type 1 
diabetes as they are dependent on insulin for survival. In such a clinical situation, 
where there are no options, care is based on diagnostic reasoning (Hallett et al. 2000, 
 20
Harbison 2001) which is similar to prescriptive decision-making (Bliss & While  
2003). 
 
People with type 2 diabetes appear to have more influence in the decision to 
commence insulin than those with type 1.  This may be due to the fact that they are 
living with diabetes prior to requiring insulin and so become knowledgeable about the 
condition and experts in their own care. Coupled with this, insulin is not a 
requirement for sustaining life and this may affect their willingness and ability to 
influence decisions about its use.  
 
Individuals’ involvement in decision-making in diabetes is an area worthy of further 
research.  Studies indicate that nurses think that patients wish for more involvement in 
their care than patients themselves actually state (Bekker et al 1999, Florin et al 2006, 
Millard et al 2006).  Our results support the view that nurses do not actively involve 
people in the decision-making process. 
 
It would appear that there are specific issues in clinical decision-making in primary 
care. Given the current philosophy to promote the management of diabetes within 
primary care, there is a need to support those in primary care to assume greater 
decision-making abilities around the initiation of insulin. 
 
While the consultant physician and the DSNSC were perceived as having ‘a lot’ of 
influence in initiating insulin therapy for people with type 1 diabetes, this influence 
was seen as less than for those with type 2 diabetes.  In this latter situation, the person 
with diabetes, the GP and the DSNPC were perceived as having greater influence 
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compared with their roles with people with type 1 diabetes.  Hoffman et al (2004) 
reported that the value of a professional’s role was a major predictor in decision-
making, and had more influence than education and experience. However, these 
differences between professionals’ perceptions of influence in those with type 1 and 
type 2 diabetes may be because of the fact that insulin is not essential for the 
maintenance of life in type 2 diabetes; or alternatively, it may indicate the growing 
confidence of primary care professionals in managing this aspect of care.   
 
DSNSCs were less likely to give consideration to patient choice or to consider their 
social situation when commencing insulin therapy. This may be because they focused 
only on the immediate clinical need or might not appreciate the personal situation of 
the individual in their social context. This would be worthy of further research.  
Further research is also needed to explore the perspectives of other multidisciplinary 
team members and people with diabetes about decision-making in relation to initiation 
of insulin therapy.    
 
Study Limitations 
The study had a number of limitations. Psychometric testing of the questionnaire for 
validity and reliability was not undertaken. The questionnaire was designed to capture 
the working practice of both teams and individual practitioners. This resulted in 
complicated analysis and presentation of results. The response rate might be 
considered low, although the same results were found within the four countries of the 
UK and there was no skewing of results. The study was conducted in the UK and, 
although the UK is leading changes in practice, further research is needed to establish 
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practice in other countries in relation to decision-making about insulin therapy 
initiation. 
 
CONCLUSION 
The person with diabetes should be central to all care delivered. Much more work is 
required to ensure that the individual is given the opportunity to be an active partner 
in decision-making about their own care. Clinical guidelines are more appropriate for 
less experienced nurses, and can be used to develop nurses in their roles. 
 
Our findings could be used to inform professional development and role expansion in 
this specialist field because they capture a change in service delivery in primary care 
as nurses are on the cusp of expanding their roles. 
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Table 1: Adults with Type 1 diabetes: Those considered to have ‘a lot’ of influence 
upon the decision to commence insulin by professional group 
 
DSN 
(Primary) 
DSN 
(Secondary) 
DSN 
(Both) 
PND  
No. % No. % No. % No. % 
GP 
 
15 16.3 18 7.8 20 10.0 81 3.5 
Physician / 
Diabetologist 
67 72.8 171 74.0 130 64.7 201 83.1 
DSN (Secondary care) 
 
32 34.8 185 80.1 141 70.1 91 37.6 
DSN (Primary care) 
 
36 39.1 45 19.5 97 48.3 42 17.4 
 
 
Table 2: Use of guidelines in diabetes   
 
 
 
Use of: Type 1 diabetes Type 2 diabetes 
Protocols 434 55.9% 659 64.9% 
Guidelines 524 66.8% 793 76.7% 
Care 
Pathways 
329 42.7% 541 53.4% 
None used 239 28.8% 195 18.0% 
 
Numbers and Percentages total more than 100 as respondents gave equal ranking to 
more than one response. 
 
 
Table 3: Most used method of determining the initial starting insulin dose  
 
  
 Type 1 Type 2 
 No. %* No. %* 
Calculation 92 19.6 119 16.0 
Doctors instruction 114 24.1 107 14.5 
Clinical experience 245 49.6 378 48.3 
Protocol / guidelines 87 18.8 246 31.9 
Team agreement 64 13.9 118 16.0 
 
* Percentages total more than 100 as respondents gave equal ranking to more than one 
response. 
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Figure 1: Decision making Type 1 vs Type 2 diabetes 
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Table 4: Adults with Type 2 diabetes: Those considered to have ‘a lot’ of influence 
upon the decision to commence insulin by professional group 
 
DSN 
(Primary) 
DSN 
(Secondary) 
DSN 
(Both) 
PND  
No. % No. % No. % No. % 
GP 
 
44 28.6 26 11.1 34 16.7 204 50.0 
Physician / 
Diabetologist 
51 33.1 156 66.7 113 55.4 143 35.0 
DSN (Secondary care) 
 
36 23.4 180 76.9 132 64.7 82 20.1 
DSN (Primary care) 
 
109 70.8 69 29.5 111 54.4 72 17.6 
Practice Nurse 
(Diabetes) 
37 24.0 20 8.5 18 8.8 192 47.1 
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